Bison Wealth’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Bison Wealth’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-8,128	Closed	-$553K	–	288
2022 Q3	$553K	Buy	+8,128	New	+$448K	0.22%	127
2020 Q3	–	Sell	-4,315	Closed	-$272K	–	398
2020 Q2	$272K	Buy	+4,315	New	+$296K	0.17%	144

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Bison Wealth's GBT Position: Q4 2022 in Review

Bison Wealth sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 8,128 shares — an estimated $553K sold.

Bison Wealth first reported a position in GBT in Q2 2020 and held it in 2 quarters. The position peaked at $553K in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

Bison Wealth reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Bison Wealth sold 8,128 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $553K.
Bison Wealth first reported a position in Global Blood Therapeutics, Inc. in Q2 2020 and held it in 2 quarters.
Bison Wealth's Global Blood Therapeutics, Inc. position peaked at $553K in Q3 2022.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Bison Wealth's 13F filing for Q4 2022, filed 10 Feb 2023.